Lijun Ma

1111 Xian Xia Road
Shanghai, 200336, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Predictive role of inflammatory markers for the efficacy of first-line immunotherapy plus chemotherapy in advanced gastric cancer.

Predictive role of inflammatory markers for the efficacy of first-line immunotherapy plus chemotherapy in advanced gastric cancer.

Journal: Discover oncology

Published: December 02, 2024

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation.

Journal: Scientific reports

Published: October 21, 2024

Corrigendum to "Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy" [Acta Biomaterialia 2020, 117, 361-373].

Corrigendum to "Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy" [Acta Biomaterialia 2020, 117, 361-373].

Journal: Acta biomaterialia

Published: August 18, 2024

Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization.

Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization.

Journal: Journal of cellular physiology

Published: May 11, 2024

Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors.

Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors.

Journal: Cell & bioscience

Published: March 29, 2024

Utidelone-based therapy in advanced or metastatic solid tumors after failure of standard therapies: a prospective, multicenter, single-arm trial.

Utidelone-based therapy in advanced or metastatic solid tumors after failure of standard therapies: a prospective, multicenter, single-arm trial.

Journal: American journal of cancer research

Published: March 18, 2024

Ailanthone targets the KMT2A-MEN1 complex to suppress lung metastasis of osteosarcoma.

Ailanthone targets the KMT2A-MEN1 complex to suppress lung metastasis of osteosarcoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 04, 2024

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

Journal: Molecular carcinogenesis

Published: June 30, 2023

Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection.

Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection.

Journal: Acta biomaterialia

Published: November 02, 2021

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.

Journal: Cancer communications (London, England)

Published: January 16, 2021

Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: An all-ages population-based cross-sectional study.

Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: An all-ages population-based cross-sectional study.

Journal: Helicobacter

Published: December 01, 2020

Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy.

Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy.

Journal: Acta biomaterialia

Published: June 24, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026